Endo will focus on restructuring initiatives and new launches in 2021 to stabilize its generics business, after the company reported a 20% drop in generics sales for the fourth quarter of 2020, with full-year sales down by more than a tenth.
“Once we are past 2021’s set of events, we are going to see a more stable generics portfolio,” assured Endo International president and CEO, Blaise Coleman, as he announced that the company would be focusing on restructuring initiatives to bolster profitability, accompanied by new launches, going forward.
After seeing its generics segment perform poorly back-to-back in the past few quarters, Endo reported a 20% drop in its...
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
Steffen Wagner has taken over as Stada’s head of Germany, adding to his existing responsibilities in Europe, after Eelco Ockers stepped down from the role. Ockers’ departure comes as German generics giant Stada restructures its business to bring its branded and consumer health interests into closer alignment as part of a more streamlined model.
Video provides a powerful way to help you prove your point. When you click Online Video, you can paste in the embed code for the video you want to add. You can also type a keyword to search online for the video that best fits your document.
